Regulation of the basal promoter activity of the human MRP4 (ABCC4) transporter

被引：0
|
作者：
Kragl, A. [1 ]
Ziems, K. [1 ]
Glaubitz, J. [1 ]
Grammbauer, S. [1 ]
Broederdorf, S. [1 ]
Cole, S. P. C. [2 ]
Tzvetkov, M. V. [1 ]
Jedlitschky, G. [1 ]
机构：
[1] Univ Med Greifswald, Dept Pharmacol, C DAT, Greifswald, Germany
[2] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2019年 / 392卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P46
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [31] Clinicopathological Impact of ABCC1/MRP1 and ABCC4/MRP4 in Epithelial Ovarian Carcinoma
    Bagnoli, Marina
    Beretta, Giovanni L.
    Gatti, Laura
    Pilotti, Silvana
    Alberti, Paola
    Tarantino, Eva
    Barbareschi, Mattia
    Canevari, Silvana
    Mezzanzanica, Delia
    Perego, Paola
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [32] The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage
    Jedlitschky, G
    Tirschmann, K
    Lubenow, LE
    Nieuwenhuis, HK
    Akkerman, JWN
    Greinacher, A
    Kroemer, HK
    BLOOD, 2004, 104 (12) : 3603 - 3610
  • [33] Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4)
    Ravna, Aina Westrheim
    Sager, Georg
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3481 - 3483
  • [34] Stabilization of Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Using Novel Solubilization Agents
    Hardy, David
    Bill, Roslyn M.
    Rothnie, Alice J.
    Jawhari, Anass
    SLAS DISCOVERY, 2019, 24 (10) : 1009 - 1017
  • [35] The human multidrug resistance protein 4 (MRP4, ABCC4):: Functional analysis of a highly polymorphic gene
    Abla, Nada
    Chinn, Leslie W.
    Nakamura, Tsutomu
    Liu, Li
    Huang, Conrad C.
    Johns, Susan J.
    Kawamoto, Michiko
    Stryke, Doug
    Taylor, Travis R.
    Ferrin, Thomas E.
    Giacomini, Kathleen M.
    Kroetz, Deanna L.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (03): : 859 - 868
  • [36] Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione
    Rius, M
    Hummel-Eisenbeiss, J
    Hofmann, AF
    Keppler, D
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (04): : G640 - G647
  • [37] Targeting multidrug resistance - associated protein 4 (MRP4/ABCC4) in pancreatic cancer
    May, M.
    Alejandro, C.
    Gomez, N.
    Diez, F.
    Copsel, S.
    Iturbe, J.
    Mohr, N.
    Fernandez, N.
    Shayo, C.
    Davio, C.
    ANNALS OF ONCOLOGY, 2016, 27 : 6 - 7
  • [38] The Multidrug Transporter MRP4/ABCC4 Involved in the Leukemia Clinical Course Specifies the Novel PEL Human Blood Group System
    Azouzi, Slim
    Mikdar, Mahmoud
    Hermand-Tournamille, Patricia
    Gautier, Emilie-Fleur
    Salnot, Virginie
    Willemetz, Alexandra
    Nicolas, Gael
    Vrignaud, Cedric
    Raneri, Alexandre
    Mayeux, Patrick
    Bole-Feysot, Christine
    Nitschke, Patrick
    Cartron, Jean-Pierre
    Aronovicz, Yves Colin
    Hermine, Olivier
    Jedlitschky, Gabriele
    Cloutier, Marc
    Constanzo-Yanez, Jessica
    Ethier, Carole
    Robitaille, Nancy
    St-Louis, Maryse
    Le Van Kim, Caroline
    Peyrard, Thierry
    BLOOD, 2019, 134
  • [39] Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
    Norris, MD
    Smith, J
    Tanabe, K
    Tobin, P
    Flemming, C
    Scheffer, GL
    Wielinga, L
    Cohn, SL
    London, WB
    Marshall, GM
    Allen, JD
    Haber, M
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) : 547 - 553
  • [40] Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes
    Wu, CP
    Klokouzas, A
    Hladky, SB
    Ambudkar, SV
    Barrand, MA
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (04) : 500 - 510
12345